Top Markets
Coin of the day
Epigenomics AG Epigenomics AG

Epigenomics AG

ECX
Kedudukan dalam Saham #38936
Founded in 1998 and headquartered in Berlin, Germany, Epigenomics AG is a... Founded in 1998 and headquartered in Berlin, Germany, Epigenomics AG is a molecular diagnostics company dedicated to the early detection of cancer through liquid biopsy methods. Its primary offering, Epi proColon, is a blood-based assay specifically developed for the early identification of colorectal cancer, distributed across the United States, Europe, and China. The company's portfolio further encompasses a blood test for hepatocellular carcinoma and Epi BiSKit, a pre-analytical solution providing reagents essential for preparing bisulfite-converted DNA. Epigenomics' research and development initiatives are focused on pinpointing relevant biomarkers in human tissue and subsequently creating and securing patents for associated in vitro diagnostic blood tests.
Harga Saham
$0.83030862
Disegerakkan terakhir: 2024-06-27
Modal Pasaran
$726.64K
Perubahan (1 hari)
-1.35%
Perubahan (1 tahun)
0.00%
Negara
DE
Perdagangan Epigenomics AG (ECX)

Kategori

Bilangan saham terbitan bagi Epigenomics AG (ECX)
Bilangan saham terbitan setakat August 2026: 0
Menurut laporan kewangan terkini dan harga saham Epigenomics AG, bilangan saham terbitan semasa ialah 0. Pada akhir August 2026, syarikat mempunyai 0 saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk Epigenomics AG (ECX) dari 2026 hingga 2026
Saham terbitan pada akhir setiap tahun
Tahun Saham Terbitan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Saham terbitan bagi syarikat atau pesaing yang serupa
Syarikat Saham Terbitan Perbezaan Negara
371.00M -
US
705.30M -
US
- -
CN
80.10M -
US
143.28M -
US